Show Notes

After reporting on the FDA Advisory Committee meeting for Biogen’s phase 3 trial drug aducanumab, Phil started wrestling with two parts of himself: should the guy who believes in science prevail, or the guy living with the diagnosis?


Questions? Comments?

If you have questions or comments for Phil (or me), please let us know! We love hearing from you 🙂